Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice
Open Access
- 1 July 2005
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (7) , 3878-3887
- https://doi.org/10.1128/iai.73.7.3878-3887.2005
Abstract
Urinary tract infections (UTIs) are among the most common bacterial infections acquired by humans, particularly in catheterized patients. A major problem with catheterization is the formation of bacterial biofilms on catheter material and the risk of developing persistent UTIs that are difficult to monitor and eradicate. To better understand the course of UTIs and allow more accurate studies of in vivo antibiotic efficacy, we developed a catheter-based biofilm infection model with mice, using bioluminescently engineered bacteria. Two important urinary tract pathogens, Pseudomonas aeruginosa and Proteus mirabilis , were made bioluminescent by stable insertion of a complete lux operon. Segments of catheter material (precolonized or postimplant infected) with either pathogen were placed transurethrally in the lumen of the bladder by using a metal stylet without surgical manipulation. The bioluminescent strains were sufficiently bright to be readily monitored from the outside of infected animals, using a low-light optical imaging system, including the ability to trace the ascending pattern of light-emitting bacteria through ureters to the kidneys. Placement of the catheter in the bladder not only resulted in the development of strong cystitis that persisted significantly longer than in mice challenged with bacterial suspensions alone but also required prolonged antibiotic treatment to reduce the level of infection. Treatment of infected mice for 4 days with ciprofloxacin at 30 mg/kg of body weight twice a day cured cystitis and renal infection in noncatheterized mice. Similarly, ciprofloxacin reduced the bacterial burden to undetectable levels in catheterized mice but did not inhibit rebound of the infection upon cessation of antibiotic therapy. This methodology easily allows spatial information to be monitored sequentially throughout the entire disease process, including ascending UTI, treatment efficacy, and relapse, all without exogenous sampling, which is not possible with conventional methods.Keywords
This publication has 62 references indexed in Scilit:
- Real-Time In Vivo Bioluminescent Imaging for Evaluating the Efficacy of Antibiotics in a Rat Staphylococcus aureus Endocarditis ModelAntimicrobial Agents and Chemotherapy, 2005
- Noninvasive Optical Imaging Method To Evaluate Postantibiotic Effects on Biofilm Infection In VivoAntimicrobial Agents and Chemotherapy, 2004
- Extracellular Replication of Listeria monocytogenes in the Murine Gall BladderScience, 2004
- Rapid Direct Method for Monitoring Antibiotics in a Mouse Model of Bacterial Biofilm InfectionAntimicrobial Agents and Chemotherapy, 2003
- Real-Time Monitoring of Bacterial Infection In Vivo: Development of Bioluminescent Staphylococcal Foreign-Body and Deep-Thigh-Wound Mouse Infection ModelsAntimicrobial Agents and Chemotherapy, 2003
- Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse ModelAntimicrobial Agents and Chemotherapy, 2003
- Understanding biofilm resistance to antibacterial agentsNature Reviews Drug Discovery, 2003
- Virulence of aProteus mirabilisATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infectionFEMS Immunology & Medical Microbiology, 2000
- Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritisJournal of Antimicrobial Chemotherapy, 1996
- The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivoJournal of Antimicrobial Chemotherapy, 1987